VIRACTA THERAPEUTICS INC

$6.20 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About VIRACTA THERAPEUTICS INC

Viracta Therapeutics, Inc. is a clinical-stage oncology company. The Company focuses on advancing new medicines for the treatment of virus-associated malignancies. Viracta Therapeutics serves customers worldwide.

Stock Analysis

last close $6.2
1-mo return -26.1%
3-mo return -44.6%
avg daily vol. 152.58T
52-week high 24.8
52-week low 3.92
market cap. $241M
forward pe -
annual div. -
roe -168.7%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 45.6%
baraka

Subscribe now for daily local and international financial news

Subscribe